View Financial HealthXebra Brands 配当と自社株買い配当金 基準チェック /06Xebra Brands配当金を支払った記録がありません。主要情報n/a配当利回りn/aバイバック利回り総株主利回りn/a将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesお知らせ • Jan 22Xebra Brands Ltd. announced that it expects to receive CAD 0.15 million in fundingXebra Brands Ltd. announced a non-brokered private placement that it will issue up to 3,000,000 units of the Company at a price of CAD 0.05 per unit for the gross proceeds of up to CAD 150,000 on January 22, 2025. Each Unit will consist of one common share of the Company and one-half of one Common Share purchase warrant. Each Warrant will entitle the holder thereof to acquire one Common Share at an exercise price of CAD 0.10 per Warrant Share at any time for a period of twenty-four months following the closing of the Offering. It is expected that the closing of the Offering will be on or about January 30, 2025, or such other date or dates that company may determine. The offering is subject to the receipt of all regulatory approvals, including the approval of the Canadian Securities Exchange. Certain directors and officers of the Company are expected to participate in the Offering.お知らせ • Jul 09Xebra Brands Successfully Completes First Manufacturing Run for Elements Brand Ahead of Growing Demand in MexicoXebra Brands Ltd. announced the successful completion of its first manufacturing run of its highly anticipated Elements line. This milestone represents a significant next step forward in Xebra Brands' commercialization efforts as the company prepares for initial distribution efforts in Mexico. The authorization for the importation, launch, and sale of the Elements Full Spectrum CBD Tinctures were granted to Elements Bioscience SAPI de C.V, a fully owned subsidiary of Xebra Brands Ltd, by Mexican regulatory authorities (COFEPRIS), and are expected to be sold in wellness and supplement stores, pharmacies and other retail channels which have accelerated their demand for new products.お知らせ • Apr 17Xebra Brands Ltd. Receives Second CBD Product Approval by COFEPRISXebra Brands Ltd. announced that it has received approval from the Federal Commission for the Protection against Sanitary Risk (COFEPRIS) for its second CBD product authorization to be sold in Mexico. This latest approval marks another milestone for Xebra Brands and highlights the Company's commitment to providing high-quality CBD products to consumers in Mexico. Building on the success of its first product approval in Mexico, Xebra Brands has obtained authorization for the transportation, launch, and sale of an additional 250mg Tincture, expanding its product offerings to meet the growing demand for premium CBD options in the region. Similar to its previously approved Tangerine Flavor CBD Tincture, this new product reflects Xebra's dedication to innovation, quality, and compliance within the CBD industry. Xebra Brands' 250mg Tincture is formulated with the same dedication to quality and purity as its previous offerings. Crafted with premium CBD extract, each batch of tincture undergoes thorough testing by third-party laboratories to ensure potency and consistency. This commitment to quality ensures that consumers in Mexico have access to trusted and reliable CBD products. With the approval of its second product by COFEPRIS, Xebra Brands reaffirms its position as a leader in the Mexican CBD industry. The company remains dedicated to meeting the evolving needs of consumers and providing natural wellness solutions that promote stress relief, relaxation, and overall well-being.お知らせ • Apr 05Xebra Brands Ltd. Submits Third Product Submission to Cofepris, Expanding Elements Brand Cbd LineupXebra Brands Ltd. announced the submission of its third product application for approval to COFEPRIS (Federal Commission for Protection Against Sanitary Risk) in Mexico for domestic production. This latest submission underscores Xebra's commitment to delivering high-quality CBD products to consumers across the country in a variety of formats. The newest addition to Xebra's Elements brand is a topical lotion meticulously crafted to provide targeted relief and nourishment for the skin, infused with premium CBD extract. Designed with precision and care, this topical lotion offers consumers a luxurious skincare experience backed by the trusted Elements brand. With the submission of the Elements Topical Lotion, Xebra now covers three major product categories in the Mexico CBD market, including topicals, tinctures, and capsules. The Company intends to continue applying for new product offerings to domestically produce products and expand into additional categories to meet the evolving needs of its consumers. Once approved by COFEPRIS, the Elements Topical Lotion will be available for purchase nationwide, providing consumers with a trusted, domestically produced solution for their skincare needs.お知らせ • Mar 08Xebra Brands Ltd. announced that it has received CAD 1 million in fundingOn March 7, 2024, Xebra Brands Ltd. closed the transaction. All of the units sold under the offering were purchased by David Ross Macias Diaz under a strategic investment agreement. Following the closing of the offering, David Ross Macias Diaz holds 18.04% and 30.56% of the common shares of the Company on a non-diluted basis and partially diluted basis, respectively. The offering is subject to the final acceptance of the CSE.お知らせ • Feb 03+ 1 more updateXebra Brands Ltd. Announces Management ChangesXebra Brands Ltd. announced a business transformation plan that will shift the Company's resources away from Canadian cannabis beverages to focus on the development and commercialization of the authorizations to manufacture cannabis products in Mexico. As part of the implementation of the Business Transformation Plan, newly appointed board member David Ross Macias Diaz has committed to an investment into the Company. Business Transformation Plan includes: Transforming the business strategy into a Mexico first model focused on generating revenues via the cannabis authorizations granted to Xebra in 2023 through partnership opportunities, listing of own products and possible M&A transactions of companies within Mexico; Scaling down the capital-intensive operations of the Company's Canadian Cannabis Beverages business; Appointing Rodrigo Gallardo as Interim-CEO to implement the Business Transformation Plan; Streamlining current corporate and operational staff to minimize cash expenditures; Realignment of current board seats from with eight (8) members to four (4) members; Revised Business Strategy. Under the Business Transformation Plan, the Company's core focus will be on commercializing the authorizations granted to Xebra an outright first-mover-advantage in Mexico, allowing Xebra and its partners to import and acquire cannabis seeds, cultivate and harvest cannabis, process and produce cannabis, and sell cannabis products both domestically and through export.お知らせ • Sep 21Xebra Brands Ltd., Annual General Meeting, Nov 07, 2023Xebra Brands Ltd., Annual General Meeting, Nov 07, 2023.お知らせ • Feb 17Xebra Brands Ltd. announced that it expects to receive CAD 0.6 million in fundingXebra Brands Ltd. announced a non-brokered private placement of up to 8,000,000 units at a price of CAD 0.075 per unit for gross proceeds of up to CAD 600,000 on February 15, 2023. Each unit consists of one common share and one half of one warrant. Each whole warrant will entitle the holder to purchase one common share at an exercise price of CAD 0.10 per share at any time within 18 months after closing. All securities to be issued in the transaction will be subject to a 4 month and one day hold period. The transaction is subject to receipt of all required regulatory and CSE approvals. The transaction is expected to close on or around March 1, 2023. The company may pay finders' fees in cash or securities, or a combination of both, as permitted by the policies of the CSE.お知らせ • Feb 04Xebra Brands Ltd. Appoints Keith Dolo to the Board of DirectorsXebra Brands Ltd. announced that Mr. Keith Dolo has been appointed to Xebra's Board of Directors. Keith is a seasoned cannabis executive and was formerly the Founder and CEO Sproutly Canada one of Canada's early Licensed Producers. He is a partner with venture capital firms Greenbridge Capital and Nautilus Capital, as well the Co-Founder of Maverick Brands which is a growth agency & accelerator that invests in, supports, and scales high growth brands across many different industries including the Cannabis and beverage industries. Keith was previously a VP at Robert Half International for over a decade.お知らせ • Jan 27+ 1 more updateXebra Announces Management ChangesXebra Brands Ltd. announced board and management changes. Robert Giustra has resigned as Chairman and Director in order to focus on his mining ventures. Mr. Giustra will remain an advisor to Xebra. Mr. Giustra is the founder of Xebra Brands; under his leadership, Xebra obtained an irrevocable injunction by the Mexican Supreme Court and created Xebra's unique beverage brands and trademarks. Over the last year Mr. Giustra transitioned the incoming CEO, and oversaw the Canadian launch of Xebra's highly successful THC and CBN infused lemonade Vicious Citrus. Daniela Freitas, Corporate Secretary have also resigned with Mr. Giustra to focus on the mining sector; Rodrigo Gallardo, Xebra's President, has been appointed CFO and Corporate Secretary on an interim basis.決済の安定と成長配当データの取得安定した配当: XBRA.Fの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: XBRA.Fの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Xebra Brands 配当利回り対市場XBRA.F 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (XBRA.F)n/a市場下位25% (US)1.4%市場トップ25% (US)4.2%業界平均 (Pharmaceuticals)2.1%アナリスト予想 (XBRA.F) (最長3年)n/a注目すべき配当: XBRA.Fは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: XBRA.Fは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: XBRA.Fの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: XBRA.Fが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YUS 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/23 04:09終値2026/04/21 00:00収益N/A年間収益N/Aデータソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Xebra Brands Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Jan 22Xebra Brands Ltd. announced that it expects to receive CAD 0.15 million in fundingXebra Brands Ltd. announced a non-brokered private placement that it will issue up to 3,000,000 units of the Company at a price of CAD 0.05 per unit for the gross proceeds of up to CAD 150,000 on January 22, 2025. Each Unit will consist of one common share of the Company and one-half of one Common Share purchase warrant. Each Warrant will entitle the holder thereof to acquire one Common Share at an exercise price of CAD 0.10 per Warrant Share at any time for a period of twenty-four months following the closing of the Offering. It is expected that the closing of the Offering will be on or about January 30, 2025, or such other date or dates that company may determine. The offering is subject to the receipt of all regulatory approvals, including the approval of the Canadian Securities Exchange. Certain directors and officers of the Company are expected to participate in the Offering.
お知らせ • Jul 09Xebra Brands Successfully Completes First Manufacturing Run for Elements Brand Ahead of Growing Demand in MexicoXebra Brands Ltd. announced the successful completion of its first manufacturing run of its highly anticipated Elements line. This milestone represents a significant next step forward in Xebra Brands' commercialization efforts as the company prepares for initial distribution efforts in Mexico. The authorization for the importation, launch, and sale of the Elements Full Spectrum CBD Tinctures were granted to Elements Bioscience SAPI de C.V, a fully owned subsidiary of Xebra Brands Ltd, by Mexican regulatory authorities (COFEPRIS), and are expected to be sold in wellness and supplement stores, pharmacies and other retail channels which have accelerated their demand for new products.
お知らせ • Apr 17Xebra Brands Ltd. Receives Second CBD Product Approval by COFEPRISXebra Brands Ltd. announced that it has received approval from the Federal Commission for the Protection against Sanitary Risk (COFEPRIS) for its second CBD product authorization to be sold in Mexico. This latest approval marks another milestone for Xebra Brands and highlights the Company's commitment to providing high-quality CBD products to consumers in Mexico. Building on the success of its first product approval in Mexico, Xebra Brands has obtained authorization for the transportation, launch, and sale of an additional 250mg Tincture, expanding its product offerings to meet the growing demand for premium CBD options in the region. Similar to its previously approved Tangerine Flavor CBD Tincture, this new product reflects Xebra's dedication to innovation, quality, and compliance within the CBD industry. Xebra Brands' 250mg Tincture is formulated with the same dedication to quality and purity as its previous offerings. Crafted with premium CBD extract, each batch of tincture undergoes thorough testing by third-party laboratories to ensure potency and consistency. This commitment to quality ensures that consumers in Mexico have access to trusted and reliable CBD products. With the approval of its second product by COFEPRIS, Xebra Brands reaffirms its position as a leader in the Mexican CBD industry. The company remains dedicated to meeting the evolving needs of consumers and providing natural wellness solutions that promote stress relief, relaxation, and overall well-being.
お知らせ • Apr 05Xebra Brands Ltd. Submits Third Product Submission to Cofepris, Expanding Elements Brand Cbd LineupXebra Brands Ltd. announced the submission of its third product application for approval to COFEPRIS (Federal Commission for Protection Against Sanitary Risk) in Mexico for domestic production. This latest submission underscores Xebra's commitment to delivering high-quality CBD products to consumers across the country in a variety of formats. The newest addition to Xebra's Elements brand is a topical lotion meticulously crafted to provide targeted relief and nourishment for the skin, infused with premium CBD extract. Designed with precision and care, this topical lotion offers consumers a luxurious skincare experience backed by the trusted Elements brand. With the submission of the Elements Topical Lotion, Xebra now covers three major product categories in the Mexico CBD market, including topicals, tinctures, and capsules. The Company intends to continue applying for new product offerings to domestically produce products and expand into additional categories to meet the evolving needs of its consumers. Once approved by COFEPRIS, the Elements Topical Lotion will be available for purchase nationwide, providing consumers with a trusted, domestically produced solution for their skincare needs.
お知らせ • Mar 08Xebra Brands Ltd. announced that it has received CAD 1 million in fundingOn March 7, 2024, Xebra Brands Ltd. closed the transaction. All of the units sold under the offering were purchased by David Ross Macias Diaz under a strategic investment agreement. Following the closing of the offering, David Ross Macias Diaz holds 18.04% and 30.56% of the common shares of the Company on a non-diluted basis and partially diluted basis, respectively. The offering is subject to the final acceptance of the CSE.
お知らせ • Feb 03+ 1 more updateXebra Brands Ltd. Announces Management ChangesXebra Brands Ltd. announced a business transformation plan that will shift the Company's resources away from Canadian cannabis beverages to focus on the development and commercialization of the authorizations to manufacture cannabis products in Mexico. As part of the implementation of the Business Transformation Plan, newly appointed board member David Ross Macias Diaz has committed to an investment into the Company. Business Transformation Plan includes: Transforming the business strategy into a Mexico first model focused on generating revenues via the cannabis authorizations granted to Xebra in 2023 through partnership opportunities, listing of own products and possible M&A transactions of companies within Mexico; Scaling down the capital-intensive operations of the Company's Canadian Cannabis Beverages business; Appointing Rodrigo Gallardo as Interim-CEO to implement the Business Transformation Plan; Streamlining current corporate and operational staff to minimize cash expenditures; Realignment of current board seats from with eight (8) members to four (4) members; Revised Business Strategy. Under the Business Transformation Plan, the Company's core focus will be on commercializing the authorizations granted to Xebra an outright first-mover-advantage in Mexico, allowing Xebra and its partners to import and acquire cannabis seeds, cultivate and harvest cannabis, process and produce cannabis, and sell cannabis products both domestically and through export.
お知らせ • Sep 21Xebra Brands Ltd., Annual General Meeting, Nov 07, 2023Xebra Brands Ltd., Annual General Meeting, Nov 07, 2023.
お知らせ • Feb 17Xebra Brands Ltd. announced that it expects to receive CAD 0.6 million in fundingXebra Brands Ltd. announced a non-brokered private placement of up to 8,000,000 units at a price of CAD 0.075 per unit for gross proceeds of up to CAD 600,000 on February 15, 2023. Each unit consists of one common share and one half of one warrant. Each whole warrant will entitle the holder to purchase one common share at an exercise price of CAD 0.10 per share at any time within 18 months after closing. All securities to be issued in the transaction will be subject to a 4 month and one day hold period. The transaction is subject to receipt of all required regulatory and CSE approvals. The transaction is expected to close on or around March 1, 2023. The company may pay finders' fees in cash or securities, or a combination of both, as permitted by the policies of the CSE.
お知らせ • Feb 04Xebra Brands Ltd. Appoints Keith Dolo to the Board of DirectorsXebra Brands Ltd. announced that Mr. Keith Dolo has been appointed to Xebra's Board of Directors. Keith is a seasoned cannabis executive and was formerly the Founder and CEO Sproutly Canada one of Canada's early Licensed Producers. He is a partner with venture capital firms Greenbridge Capital and Nautilus Capital, as well the Co-Founder of Maverick Brands which is a growth agency & accelerator that invests in, supports, and scales high growth brands across many different industries including the Cannabis and beverage industries. Keith was previously a VP at Robert Half International for over a decade.
お知らせ • Jan 27+ 1 more updateXebra Announces Management ChangesXebra Brands Ltd. announced board and management changes. Robert Giustra has resigned as Chairman and Director in order to focus on his mining ventures. Mr. Giustra will remain an advisor to Xebra. Mr. Giustra is the founder of Xebra Brands; under his leadership, Xebra obtained an irrevocable injunction by the Mexican Supreme Court and created Xebra's unique beverage brands and trademarks. Over the last year Mr. Giustra transitioned the incoming CEO, and oversaw the Canadian launch of Xebra's highly successful THC and CBN infused lemonade Vicious Citrus. Daniela Freitas, Corporate Secretary have also resigned with Mr. Giustra to focus on the mining sector; Rodrigo Gallardo, Xebra's President, has been appointed CFO and Corporate Secretary on an interim basis.